Insufficient scRNA-seq data for expression of PASD1 at single-cell level.
Insufficient scRNA-seq data for expression of PASD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 36% | 1.44 | 65 / 180 | 2% | 0.66 | 10 / 430 |
skin | 23% | 1.11 | 420 / 1809 | 9% | 2.81 | 43 / 472 |
bladder | 29% | 2.48 | 6 / 21 | 2% | 0.51 | 11 / 504 |
muscle | 27% | 1.07 | 214 / 803 | 0% | 0 | 0 / 0 |
esophagus | 22% | 1.00 | 314 / 1445 | 3% | 0.70 | 5 / 183 |
brain | 24% | 0.94 | 637 / 2642 | 0% | 0 | 0 / 705 |
intestine | 22% | 0.78 | 213 / 966 | 1% | 0.11 | 5 / 527 |
lung | 18% | 0.61 | 103 / 578 | 5% | 0.83 | 57 / 1155 |
thymus | 22% | 1.06 | 141 / 653 | 0% | 0.07 | 2 / 605 |
uterus | 19% | 1.02 | 32 / 170 | 2% | 0.32 | 10 / 459 |
adipose | 20% | 0.85 | 243 / 1204 | 0% | 0 | 0 / 0 |
heart | 19% | 0.58 | 166 / 861 | 0% | 0 | 0 / 0 |
breast | 17% | 0.95 | 79 / 459 | 1% | 0.02 | 6 / 1118 |
blood vessel | 17% | 0.65 | 233 / 1335 | 0% | 0 | 0 / 0 |
stomach | 10% | 0.27 | 37 / 359 | 4% | 0.94 | 11 / 286 |
adrenal gland | 13% | 0.40 | 34 / 258 | 0% | 0.17 | 1 / 230 |
prostate | 12% | 1.39 | 30 / 245 | 0% | 0 | 0 / 502 |
liver | 11% | 0.55 | 25 / 226 | 1% | 0.09 | 4 / 406 |
peripheral blood | 11% | 0.36 | 102 / 929 | 0% | 0 | 0 / 0 |
pancreas | 10% | 0.23 | 32 / 328 | 0% | 0 | 0 / 178 |
spleen | 8% | 0.24 | 19 / 241 | 0% | 0 | 0 / 0 |
kidney | 6% | 0.18 | 5 / 89 | 1% | 0.30 | 5 / 901 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.95 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042754 | Biological process | negative regulation of circadian rhythm |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_1990513 | Cellular component | CLOCK-BMAL transcription complex |
GO_1990512 | Cellular component | Cry-Per complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | PASD1 |
Protein name | Circadian clock protein PASD1 (Cancer/testis antigen 63) (CT63) (OX-TES-1) (PAS domain-containing protein 1) |
Synonyms | |
Description | FUNCTION: Functions as a suppressor of the biological clock that drives the daily circadian rhythms of cells throughout the body . Acts as a nuclear repressor of the CLOCK-BMAL1 heterodimer-mediated transcriptional activation of the core clock components . Inhibits circadian clock function in cancer cells, when overexpressed . . |
Accessions | Q8IV76 ENST00000370357.5 [Q8IV76-1] |